glp-1 and migraines Activation of microglial GLP-1R in the trigeminal nucleus caudalis suppresses central sensitization of chronic migraine after recurrent nitroglycerin stimulation | The Journal of Headache Pain New findings show a link

If palpitations started after a change in medication brand, timing, diet, or digestive health, that timeline is essential to share with your clinician

Free radical formation causes oxidative stress, resulting in hair follicle miniaturization and problems with hair growth

Currently, there are ten classes of orally available pharmacological agents to treat T2DM: 1) sulfonylureas (SU), 2) meglitinides, 3) metformin (a biguanide), 4) thiazolidinediones (TZDs), 5) alpha glucosidase inhibitors, 6) dipeptidyl peptidase IV (DPP-4) inhibitors, 7) bile acid sequestrants, 8) dopamine agonists, 9) sodium-glucose transport protein 2 (SGLT2) inhibitors and 10) oral glucagon like peptide 1 (GLP-1) receptor agonists (6-8)

The 85-year-old Detroit native says that what motivates him is seeing people happily relocate to a community that bustles with youthful energy